FirstService Corp recently reported a significant transaction involving its director Fred Reichheld. In a filing with the SEC, Reichheld disclosed the sale of 7,200 shares of the company's common stock, valued at approximately $1.13 million. This transaction is noteworthy as it highlights ongoing adjustments in the company's equity positions.
The sale took place on November 10, 2026, and follows a previous transaction on November 6, 2026, where Reichheld sold 6,000 shares for gross proceeds of about $918,000. Such insider transactions can provide insights into the company's internal dynamics and the confidence of its leadership in the company's future.
Background
FirstService Corp operates within the real estate sector, classified under SIC code 6500. The company is publicly traded on the Nasdaq under the ticker symbol FSV. Known for its diverse range of services in real estate and property management, FirstService Corp has been active in the market, as indicated by its recent filings.
What the Filing Says
The SEC filing, accession number 0001959173-26-007926, details that Fred Reichheld, a director at FirstService Corp, sold 7,200 shares of common stock. The filing states, "The approximate sale date was 11/10/2026," and notes that the shares were acquired through a stock option exercise.
Impact
This transaction may affect various stakeholders, including shareholders and potential investors, as insider selling can influence market perceptions. The real estate sector, where FirstService operates, may also see broader implications as companies adjust their equity strategies in response to market conditions.
What's Next
The filing does not say what happens next regarding further transactions or company strategies.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










